{"id":"W2141917836","doi":"10.2967/jnumed.106.037937","title":"111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Nuclear Medicine","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto","funders":"Connaught Fund; Cancer Research UK; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Trastuzumab; HER2/neu; NLS; Breast cancer; Cancer research; Medicine; Chemistry; Nuclear localization sequence; Oncology; Cancer; Internal medicine; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001631718,0.0003311176,0.0002245564,0.0001148258,0.00007733032,0.0001892462,0.0002396937,0.000355772,0.0006464919],"category_scores_gemma":[0.0001419593,0.0001064726,0.0001074739,0.0001377954,0.0002266644,0.0001658877,0.0001673876,0.0001694864,0.0002170242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004075166,"about_ca_system_score_gemma":0.0001840748,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003369292,"about_ca_topic_score_gemma":0.0004246611,"domain_scores_codex":[0.9998916,0.00002590151,0.000006101716,0.00002114098,0.00003118992,0.00002397054],"domain_scores_gemma":[0.9999281,0.00001367801,0.00002582559,0.000008031456,0.00001276385,0.00001149575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001036708,0.00001421939,0.0002538114,0.00004811193,0.000002943533,0.0000391845,0.000007101587,0.0001357179,0.9981725,0.00006625442,0.00003093521,0.001125452],"study_design_scores_gemma":[0.00002332097,0.0002674931,0.001760718,0.00000541269,0.00001209624,0.0004169707,0.000008192208,0.000715013,0.9945968,0.000014607,0.002176068,0.000003117678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904208,0.00263272,0.004878817,0.0001027781,0.00002147242,0.00003171439,0.00007739872,0.00006760565,0.00176669],"genre_scores_gemma":[0.9904023,0.001444442,0.00524691,0.0000523829,0.00001441374,0.00002447773,0.0002583541,0.00001554351,0.002541068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006464919,"threshold_uncertainty_score":0.002956748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05070695068423739,"score_gpt":0.3885682893699564,"score_spread":0.337861338685719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}